Global Linear Particle Accelerators Market Report 2024

The linear particle accelerators market size has grown strongly in recent years. It will grow from $2.44 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The historical growth can be attributed to several factors, including increased demand for cancer treatment, government initiatives and funding, improved treatment outcomes, expansion of healthcare facilities, and collaboration and partnerships.

The linear particle accelerators market size is expected to see strong growth in the next few years. It will grow to $3.28 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The increase expected in the forecast period is due to a heightened need for precision medicine, greater use of proton therapy, an aging population, emerging markets, and increased investments in research and development. Key trends in this period involve incorporating artificial intelligence, expanding the use of proton therapy, personalized medicine strategies, minimally invasive treatments, and global market growth.

The increasing emphasis on precision medicine is expected to drive the growth of the linear particle accelerators market in the future. Precision medicine involves tailoring medical treatments to individual patients based on their unique characteristics, and its growing prominence is attributed to advancements in genomic research and technology. This approach acknowledges the limitations of traditional healthcare methods and recognizes the potential of personalized treatments for better patient outcomes. Linear particle accelerators play a crucial role in precision medicine by delivering targeted radiation therapy, enabling precise targeting of tumors while minimizing damage to surrounding healthy tissues. In 2022, the Personalized Medicine Coalition reported that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of therapeutic NMEs classified as personalized medicines by the coalition. This statistic highlights the impact of the increasing focus on precision medicine on the linear particle accelerators market.

Major companies in the linear particle accelerators market are developing innovative solutions, such as AI-powered adaptive computed tomography linear particle accelerators (CT-Linac), to transform cancer treatment. These advanced devices integrate artificial intelligence algorithms with computed tomography technology and particle acceleration capabilities to provide precise, personalized radiation therapy treatments with real-time imaging and adaptive treatment planning. For instance, in May 2024, Elekta launched Elekta Evo, an AI-powered adaptive CT-Linac designed for radiation therapy. This linear particle accelerator offers clinicians unprecedented precision and versatility in cancer treatments, thanks to its next-generation imaging quality and online adaptability capabilities. Elekta Evo utilizes cutting-edge imaging technologies, anatomy-specific algorithms, and potent AI to optimize treatment planning, minimize damage to organs at risk, and reduce uncertainties.

In April 2021, Siemens Healthineers AG acquired Varian Medical Systems Inc., aiming to integrate Varian’s radiation therapy and software solutions with Siemens Healthineers' advanced imaging technologies. This strategic acquisition enhances cancer treatment outcomes by improving diagnostics precision and offering personalized therapies through combined expertise in linear accelerators and imaging technologies.

Major companies operating in the linear particle accelerators market are Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Philips, Beckman Coulter Inc., Carl Zeiss, Elekta AB, Neusoft Corporation, Shinva Medical Instrument Co. Ltd., ALCEN, Laird Technologies, Accuray Incorporated, Brainlab AG, AccSys Technology, Mevion Medical Systems, Viewray Medical Technologies Inc., RefleXion Medical, Panacea Medical Technologies Pvt. Ltd., Altair Technologies, Sordina lort Technologies, MedAustron, LUM GmbH, IBA Group, P-Cure Ltd.

North America was the largest region in the linear particle accelerators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the linear particle accelerators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linear particle accelerators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A linear particle accelerator is a device utilized in particle physics to accelerate charged particles, such as electrons, protons, or ions, to very high speeds. It serves as a fundamental tool in numerous areas of scientific research, including high-energy physics, nuclear physics, and medical radiation therapy.

The primary types of linear particle accelerators include low-energy machines, medium-energy machines, and high-energy machines. Low-energy machines are characterized by energy outputs typically below 10 MeV (mega-electron volts) and are employed for research purposes and industrial applications such as material testing and non-destructive analysis. They are also utilized in various therapies such as radiosurgery and radiation therapy, treating conditions such as prostate cancer, breast cancer, lung cancer, head and neck cancers, colorectal cancers, among others. These machines find applications in various end-user settings including radiology clinics, hospitals, and others.

The linear particle accelerators market research report is one of a series of new reports that provides linear particle accelerators market statistics, including linear particle accelerators industry global market size, regional shares, competitors with a linear particle accelerators market share, detailed linear particle accelerators market segments, market trends and opportunities, and any further data you may need to thrive in the linear particle accelerators industry. This linear particle accelerators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The linear particle accelerators market consists of sales of accelerating cavities, RF (Radio Frequency) power sources, waveguides and couplers, beam diagnostic instruments, beam control systems, and cooling systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.